GenIP returns to the market for a third time in a year as cash dwindles

GenIP has suspended its shares to raise fresh equity to fund the rollout of a new platform for clients that will offer subscription services.

It will be GenIP’s third fundraise in less than a year after two deeply discounted placings which the share price has never recovered from.

- Advertisement -

The AI-driven technology commercialisation group said on Tuesday it had opened an AIM Capital Access Window to run a fundraise through its broker, AlbR Capital. The cash is earmarked to launch its Invention Evaluator Platform and strengthen working capital.

GenIP did not disclose either the amount it is seeking or the issue price for the current fundraising.

GenIP’s third placing in a year

This is the third time GenIP has gone to the market in under twelve months.

In December 2025, AlbR placed 3 million shares at 10p to raise £300,000. That price was a 46% discount to the 18.5p mid-price at the time, and each share came with a warrant exercisable at 20p. A further £350,000 placing followed in April 2026 at 7p.

- Advertisement -

GenIP was trading at around 2.6p before the capital access window suspended trading yesterday, roughly three-quarters below the December placing price. GenIP listed at 39p in October 2024; the share price is down 93% since.

With no price yet set on the current fundraising round, existing holders face the prospect of another highly dilutive issue below an already depressed share price.

A commercial update short of detail

GenIP released a commercial update hours before the suspension that was thin on signed business but offered some positivity on pilots.

In the announcement, the company appears to have published the most optimistic numbers it could muster immediately before launching the fundraise.

GenIP said 17 pilot accounts could represent “a potential annual subscription value of around US$170,000”. It also put its total addressable market at roughly $50 million a year and its sales pipeline at about $1 million.

One significant 2025 customer has agreed to “initiate the migration plan”, but there was no detail on what this could mean in terms of potential revenue.

The pipeline includes opportunities with organisations “associated with” Saudi Aramco and proposal discussions with Amazon Web Services in Brazil, but no orders. New customers won in Chile and Brazil came in with no values attached.

GenIP’s slower cash burn is still a burn

The board said it expects to reduce cash burn by around 40% in 2027 as the business moves to a subscription model. That is a reduction in cash burn, suggesting they’ll burn 60% of the cash next year, as they have this year. The company gave no timetable for reaching cash-flow break-even.

Based on recent numbers, a 40% cut in cash burn would still leave a significant gap to fill with increased sales, which have been weak, to say the least.

GenIP formed from Tekcapital’s spin-out of two services, Invention Evaluator and Vortechs, which generated roughly $280,000 in revenue for Tekcapital in 2023. Despite GenIP claiming it enhanced these products with AI, it generated just $53k in revenue in the first half of 2026 after so far failing to secure a rebooking from a Saudi client that accounted for most of 2026’s revenue.

GenIP’s adjusted EBITDA loss widened to $692K in the first half of 2026, from $561K a year earlier. Cash stood at $410K at 30 June, after the April placement.

Tekcapital has since invested $200k via a convertible loan note convertible at the share price on the day of conversion. This could lead to further dilution down the road.

In an announcement released in 2025, GenIP said orders won at the time ‘help maintain the Company’s strong financial position’. Unfortunately for investors who have held since then, this hasn’t proved to be the case.

Latest News

More Articles Like This